Dietary and nutrition considerations in caring for patients with nonalcoholic fatty liver disease: Updates for the practicing clinician

被引:2
作者
Newberry, Carolyn [1 ]
Kumar, Sonal [1 ]
机构
[1] Weill Cornell Med Ctr, Innovat Ctr Hlth & Nutr Gastroenterol ICHANGE, Div Gastroenterol, 1305 York Ave,4th Floor, New York, NY 10021 USA
关键词
fatty liver; liver diseases; micronutrients; nonalcoholic fatty liver disease; nutrition assessment; nutrition therapy; obesity; COFFEE CONSUMPTION; WEIGHT-LOSS; VITAMIN-E; RISK; MANAGEMENT; ASSOCIATION; FRUCTOSE; OBESITY; CANCER; CARBOHYDRATE;
D O I
10.1002/ncp.10917
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Nonalcoholic fatty liver disease (NAFLD) is the leading cause of chronic liver disease worldwide, affecting up to one-third of the global population. The disease is defined by excess fat deposition in the liver and has a strong correlation with metabolic syndrome, which, in turn, is also a risk factor for disease progression, including the development of steatohepatitis, advanced fibrosis, cirrhosis, and hepatocellular carcinoma. Although a number of medications are being explored for disease mitigation, nothing is currently approved, and the mainstay of therapy remains dietary and lifestyle intervention that promotes weight loss as well as management of comorbid conditions. The landscape that guides care for patients with NAFLD continues to evolve. Clinicians caring for these patients need to consider underlying disease state and nutrition risk in addition to concurrent related diagnoses, such as insulin resistance and hyperlipidemia, when formulating treatment plans. The following is a comprehensive review of the current dietary and nutrition considerations in the management of patients with NAFLD, with a special emphasis on implications for the practicing clinician.
引用
收藏
页码:70 / 79
页数:10
相关论文
共 56 条
  • [31] Association of Weight Loss Interventions With Changes in Biomarkers of Nonalcoholic Fatty Liver Disease A Systematic Review and Meta-analysis
    Koutoukidis, Dimitrios A.
    Astbury, Nerys M.
    Tudor, Kate E.
    Morris, Elizabeth
    Henry, John A.
    Noreik, Michaela
    Jebb, Susan A.
    Aveyard, Paul
    [J]. JAMA INTERNAL MEDICINE, 2019, 179 (09) : 1262 - 1271
  • [32] Multidisciplinary Clinic Models: A Paradigm of Care for Management of NAFLD
    Kumar, Sonal
    Wong, Rochelle
    Newberry, Carolyn
    Yeung, Michele
    Pena, Jessica M.
    Sharaiha, Reem Z.
    [J]. HEPATOLOGY, 2021, 74 (06) : 3472 - 3478
  • [33] Li Andrew A, 2020, Clin Liver Dis (Hoboken), V16, P73, DOI 10.1002/cld.900
  • [34] Effect of Selenium and Vitamin E on Risk of Prostate Cancer and Other Cancers The Selenium and Vitamin E Cancer Prevention Trial ( SELECT)
    Lippman, Scott M.
    Klein, Eric A.
    Goodman, Phyllis J.
    Lucia, M. Scott
    Thompson, Ian M.
    Ford, Leslie G.
    Parnes, Howard L.
    Minasian, Lori M.
    Gaziano, J. Michael
    Hartline, Jo Ann
    Parsons, J. Kellogg
    Bearden, James D., III
    Crawford, E. David
    Goodman, Gary E.
    Claudio, Jaime
    Winquist, Eric
    Cook, Elise D.
    Karp, Daniel D.
    Walther, Philip
    Lieber, Michael M.
    Kristal, Alan R.
    Darke, Amy K.
    Arnold, Kathryn B.
    Ganz, Patricia A.
    Santella, Regina M.
    Albanes, Demetrius
    Taylor, Philip R.
    Probstfield, Jeffrey L.
    Jagpal, T. J.
    Crowley, John J.
    Meyskens, Frank L., Jr.
    Baker, Laurence H.
    Coltman, Charles A., Jr.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 301 (01): : 39 - 51
  • [35] Cardiovascular Risk in NAFLD: An Intimate Relationship?
    Lonardo, Amedeo
    Targher, Giovanni
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2020, 65 (06) : 1593 - 1595
  • [36] A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis
    Newsome, Philip N.
    Buchholtz, Kristine
    Cusi, Kenneth
    Linder, Martin
    Okanoue, Takeshi
    Ratziu, Vlad
    Sanyal, Arun J.
    Sejling, Anne-Sophie
    Harrison, Stephen A.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (12) : 1113 - 1124
  • [37] Fructose consumption as a risk factor for non-alcoholic fatty liver disease
    Ouyang, Xiaosen
    Cirillo, Pietro
    Sautin, Yuri
    McCall, Shannon
    Bruchette, James L.
    Diehl, Anna Mae
    Johnson, Richard J.
    Abdelmalek, Manal F.
    [J]. JOURNAL OF HEPATOLOGY, 2008, 48 (06) : 993 - 999
  • [38] Bioelectrical impedance analysis is a useful bedside technique to assess malnutrition in cirrhotic patients with and without ascites
    Pirlich, M
    Schütz, T
    Spachos, T
    Ertl, S
    Weiss, ML
    Lochs, H
    Plauth, M
    [J]. HEPATOLOGY, 2000, 32 (06) : 1208 - 1215
  • [39] ESPEN guideline on clinical nutrition in liver disease
    Plauth, Mathias
    Bernal, William
    Dasarathy, Srinivasan
    Merli, Manuela
    Plank, Lindsay D.
    Schuetz, Tatjana
    Bischoff, Stephan C.
    [J]. CLINICAL NUTRITION, 2019, 38 (02) : 485 - 521
  • [40] Vitamins and non-alcoholic fatty liver disease: A molecular insight
    Raza, Sana
    Tewari, Archana
    Rajak, Sangam
    Sinha, Rohit A.
    [J]. LIVER RESEARCH, 2021, 5 (02) : 62 - 71